Versatile Jak2 Polyclonal Antibody Reactivity Human - Limited Release [PRKUOsf7]

JAK2 Polyclonal Antibody: Advanced Research Tool

The Versatile Jak2 Polyclonal Antibody Reactivity Human - Limited Release [PRKUOsf7] is a cutting-edge research tool designed for investigating the essential signaling pathway involved in various cellular processes. This antibody, raised in rabbits, offers a robust and specific binding to the human JAK2 protein, ensuring reliable and reproducible results in various applications. Its reactivity extends to mouse and rat species, making it a versatile choice for comparative studies across different organisms.

Product Specifications and Features

The JAK2 Polyclonal Antibody is characterized by its high purity and specificity, thanks to its affinity purification process. It is conjugated with a rabbit IgG, which ensures optimal immunogenicity and compatibility with various immunoassays. The antibody recognizes the human JAK2 protein at a calculated molecular weight of 131 kDa and an observed molecular weight of 130 kDa. It is also capable of localizing to the endomembrane system and the nucleus, reflecting its involvement in signal transduction and chromatin modification. Key features include:

• Reactivity: Human, Mouse, Rat
• Applications: WB, IHC-p, IF
• Clonality: Polyclonal

Applications and Benefits

This JAK2 Polyclonal Antibody is a valuable asset for researchers studying cancer, cell biology, epigenetics, and signal transduction. Its ability to detect and analyze JAK2 in various applications such as Western blotting, immunohistochemistry, and immunofluorescence makes it an indispensable tool in the lab. By promoting the localization of EPO receptors and mediating histone H3 phosphorylation, this antibody aids in understanding the complex interplay between JAK2 and various signaling pathways. Its use can lead to:

• Enhanced Research Capabilities: Provides reliable and reproducible results in various applications.
• Target Audience: Ideal for researchers in cancer, cell biology, and signal transduction fields.